NCT06174129View on ClinicalTrials.gov

Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

427

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

July 31, 2023

Conditions
Atrial FibrillationType 2 Diabetes
Interventions
OTHER

Routine examinations

Electrocardiography and clinical parameters examinations, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications

Trial Locations (1)

20131

Burapha University Hospital, Mueang

All Listed Sponsors
lead

Burapha University

OTHER